Pcv35 - Secondary Prevention for Cardiovascular Disease: Definition of Population and Evaluation of Outcomes Using Real World Data

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.582
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Omega-6 Fats for the Primary and Secondary Prevention of Cardiovascular Disease

Cochrane Database of Systematic Reviews
2018English

PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease

2015English

Omega-3 Fatty Acids for the Primary and Secondary Prevention of Cardiovascular Disease

Cochrane Database of Systematic Reviews
2020English

Post-Myocardial Infarction (MI) Care: Medication Adherence for Secondary Prevention After MI in a Large Real-World Population

Clinical Therapeutics
Pharmacology
2019English

Primary Prevention of Cardiovascular Disease Through Population-Wide Motivational Strategies: Insights From Using Smartphones in Stroke Prevention

BMJ Global Health
Health PolicyPublic HealthOccupational HealthEnvironmental
2017English

Aspirin for Prevention of Cardiovascular Disease

Preventing chronic disease
Health PolicyPublic HealthOccupational HealthEnvironmental
2017English

Aspirin for Prevention of Cardiovascular Disease

JAMA - Journal of the American Medical Association
Medicine
2020English

Critical Challenges of Economic and Social Issues in Secondary Prevention of Cardiovascular Disease

Journal of Family Medicine and Disease Prevention
2019English

The Role of mHealth Technology in the Secondary Prevention of Cardiovascular Disease

Romanian Biotechnological Letters
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy